en
Scientific article
Open access
English

Patient and public involvement in the benefit-risk assessment and decision concerning health products : position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)

Published inBMJ global health, vol. 8, no. 5, e011966
Publication date2023-05
Keywords
  • Health policy
  • Health systems evaluation
  • Public health
  • Treatment
  • Humans
  • Risk Assessment
  • Public Health
Citation (ISO format)
BELGODÈRE, Laëtitia et al. Patient and public involvement in the benefit-risk assessment and decision concerning health products : position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM). In: BMJ global health, 2023, vol. 8, n° 5, p. e011966. doi: 10.1136/bmjgh-2023-011966
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2059-7908
20views
1downloads

Technical informations

Creation02/06/2024 11:19:37 AM
First validation06/05/2024 7:41:02 AM
Update time06/05/2024 7:41:02 AM
Status update06/05/2024 7:41:02 AM
Last indexation06/05/2024 7:41:22 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack